Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent Advances

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Cancer is a leading cause of death, characterized by uncontrolled cell growth.
• Developing effective cancer treatments that overcome drug resistance and minimize side effects is crucial.
• Benzimidazole derivatives are recognized for their diverse pharmacological actions and anticancer properties.

Purpose of the Study:

• To review benzimidazole hybrids' anticancer significance, mechanisms of action, and structure-activity relationships.
• To consolidate research on benzimidazole-based anticancer agents from 2005 to 2025.
• To inform the design of novel, effective anticancer drugs.

Main Methods:

• Literature review of scientific reports on benzimidazole hybrids.
• Analysis of anticancer properties and mechanisms of action.
• Examination of structure-activity relationships.

Main Results:

• Benzimidazole derivatives exhibit multiple anticancer activities through various mechanisms.
• These compounds can act as nucleotide isosteres, influencing cellular processes.
• Several benzimidazole-based drugs are already approved for cancer treatment.

Conclusions:

• Benzimidazole hybrids represent a valuable scaffold for developing next-generation anticancer drugs.
• Understanding their diverse mechanisms and SAR is key to optimizing therapeutic strategies.
• Further research into benzimidazole derivatives holds significant potential for cancer therapy.